OTTAVIANI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 2.242
EU - Europa 217
AS - Asia 56
OC - Oceania 3
SA - Sud America 3
Totale 2.521
Nazione #
US - Stati Uniti d'America 2.240
IT - Italia 68
IE - Irlanda 47
CN - Cina 27
UA - Ucraina 20
SE - Svezia 16
DE - Germania 15
GB - Regno Unito 13
RU - Federazione Russa 11
SG - Singapore 9
FR - Francia 8
BE - Belgio 5
IN - India 5
KR - Corea 5
NL - Olanda 5
AU - Australia 3
BR - Brasile 3
CA - Canada 2
FI - Finlandia 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
NO - Norvegia 2
PH - Filippine 2
VN - Vietnam 2
ES - Italia 1
ID - Indonesia 1
LK - Sri Lanka 1
PL - Polonia 1
RO - Romania 1
Totale 2.521
Città #
Wilmington 682
Houston 660
Woodbridge 283
Fairfield 120
Chandler 75
Ashburn 59
Dublin 40
Cambridge 39
New York 38
Seattle 38
Ann Arbor 36
Rome 32
Dearborn 23
Medford 21
Lawrence 10
Beijing 8
Moscow 7
Singapore 7
Boardman 6
Jacksonville 6
Brussels 5
Kilburn 5
Milan 5
Los Angeles 4
Menlo Park 4
Redwood City 4
Centrale 3
Creede 3
Jinan 3
London 3
Nanjing 3
San Diego 3
Dong Ket 2
Engelhard 2
Guangzhou 2
Hackensack 2
Hanover 2
Hull 2
Kendall Park 2
Lecce 2
Monte Vista 2
Mountain View 2
Norwalk 2
Oslo 2
Pune 2
Renton 2
Rockdale 2
Roebling 2
San Francisco 2
Seoul 2
Sesto Fiorentino 2
Shanghai 2
São Paulo 2
Turin 2
Ardabil 1
Ariccia 1
Baltimore 1
Bari 1
Billerica 1
Brisbane 1
Buffalo 1
Casalnuovo Di Napoli 1
Cerveteri 1
Changsha 1
Chapel Hill 1
Chicago 1
Chiswick 1
Chongqing 1
Cluj-napoca 1
Cornaredo 1
Denia 1
Groningen 1
Hounslow 1
Islington 1
Kraków 1
Kunming 1
La Canada Flintridge 1
Latina 1
Manila 1
Munich 1
Nanchang 1
Nuremberg 1
Phoenix 1
Pomezia 1
Prescot 1
Quezon City 1
Redmond 1
Rosmalen 1
Saint Petersburg 1
Shenyang 1
St. George 1
Surabaya 1
Taranto 1
Utrecht 1
Venezia 1
Zhengzhou 1
Totale 2.321
Nome #
Simulative and experimental characterization of a pH-dependent clamp-like DNA triple-helix nanoswitch 432
Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation 370
Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors 329
Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages 326
Engineering a responsive DNA triple helix into an octahedral DNA nanostructure for a reversible opening/closing switching mechanism: a computational and experimental integrated study 273
In vitro elimination of EGFR-overexpressing cancer cells by CD32A chimeric receptor T cells in combination with cetuximab or panitumumab 262
Real-time analysis of cleavage and religation activity of human topoisomerase 1 based on ternary fluorescence resonance energy transfer DNA substrate 160
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab 158
Imbibition of Femtoliter-Scale DNA-Rich Aqueous Droplets into Porous Nylon Substrates by Molecular Printing 155
In vitro and in silico characterization of an antimalarial compound with antitumor activity targeting human DNA topoisomerase IB 42
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment 34
Topoisomerase IB: a relaxing enzyme for stressed DNA 22
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B 20
Natural compounds as therapeutic agents: The case of human topoisomerase ib 11
EGFR+ Glioblastoma stem cells targeting by CD16158V-chimeric receptor T cells and cetuximab 7
Totale 2.601
Categoria #
all - tutte 6.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020866 47 41 47 64 62 103 97 94 93 84 72 62
2020/2021623 67 70 69 77 76 66 68 62 22 27 9 10
2021/2022131 4 6 4 10 3 13 8 12 5 27 9 30
2022/2023220 17 21 2 33 22 39 37 15 18 0 13 3
2023/2024155 15 9 13 4 21 51 8 6 5 2 1 20
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.601